80-year-old antibiotic redesigned for new medical uses

October 04, 2020

Physicians and scientists have long searched the natural world for chemicals that can improve human health. However, evolutionary selection optimized natural chemicals to benefit their host, not for safety or efficacy in humans. This mismatch inspired chemists at the University of Tokyo to alter useful natural products for better, safer use in people. Their approach has transformed one of the world's oldest antibiotics into versions that - in preliminary lab tests - appear to be safer, stronger drugs.

Gramicidin A was originally discovered in soil bacteria and became the first commercially manufactured antibiotic in the early 1940s. It continues to be prescribed by doctors today as a topical cream or drops for some skin, eye and throat infections, but it cannot be used as a pill or injection. Gramicidin A kills bacteria by punching itself through the cell membrane, essentially allowing the cell to leak out and the world to leak in through nano-sized tunnels called ion channels. These unregulated ion channels wreak the same havoc on human cells when gramicidin A is used inside the body.

Scientists have long been fascinated by the ion channel function of gramicidin A because ion channels are nearly universal among living things. Human ion channels are involved in everything from brain function to blood pressure. About 350 artificial analogs of gramicidin A have been developed over the past 80 years, all of which have properties similar to the original and thus cannot be used in humans.

Now, a team from the University of Tokyo Department of Pharmaceutical Sciences has designed and analyzed over 4,000 gramicidin A artificial analogs.

"Usually, natural product synthesis is a very difficult, complicated task. There are many steps to make these large molecules and at the end, synthetic yields are very low, so synthetic approaches like the one bead-one compound synthesis we used are still uncommon with natural products," said Assistant Professor Hiroaki Itoh, one of the authors of the research publication in Nature Communications.

Gramicidin A is a spiral of 15 amino acids, the building blocks of peptides, which are short proteins. Researchers strategically selected six of those amino acids that could be altered without losing essential aspects of gramicidin A's normal structure. Each of those six amino acids could be exchanged with four different amino acids to change how the peptide bonds together, leading to a total of 4,096 variations.

The one-bead-one-compound synthesis technique begins with small glass beads serving as the foundation to attach the first amino acid. Researchers build the peptide by attaching more amino acids one at a time. Whenever they reach the point of an amino acid variation, they split the beads into equal portions corresponding to the different amino acids, then remix the beads and continue building the peptide.

After completing their synthesis, researchers placed each bead into its own container and analyzed the function of their new versions of gramicidin A.

"Actually, this was a fully manual operation. It was a struggle for the student in charge of the project, but she is a very hard worker and made a great accomplishment with this research. Considering the normal timeline of natural product chemistry, this was quick," said Itoh. The student, Yuri Takada, who subsequently received her doctoral degree, is the first author of the research paper and is now working as a postdoctoral researcher at the University of Cambridge in the U.K.

Researchers began testing their new versions of gramicidin A for activity against the common bacterial infection streptococcus. The strongest performers were then assessed for their potential ability to not indiscriminately kill human cells by testing their reactions with rabbit blood cells and mouse leukemia cells.

These tests identified about 10 gramicidin A variations as promising future antibacterial drugs. The results also allowed researchers to identify how specific structural changes to the amino acids affect the overall function of the molecule. This foundational structure-function information is crucial for understanding why and how pharmaceuticals work.

Researchers also measured the ion channel-forming ability of the best performing new versions of gramicidin A. Although they had reduced toxicity to mammalian cells, their ion channel-forming ability remained strong. These subtle modifications to a few amino acids could transform gramicidin A's ion channel-forming function from indiscriminate to bacteria specific.

"Most important is that this strategy can be used for other types of natural products and other ion channel-forming compounds. It has long been believed to be very difficult to realize species-selective ion channel-forming activity, but our study showed gramicidin A can have very bacteria-selective activity. I believe this thought can change the standard of ion channel-forming natural products," said Itoh.
-end-
Research Article
Yuri Takada, Hiroaki Itoh, Atmika Paudel, Suresh Panthee, Hiroshi Hamamoto, Kazuhisa Sekimizu, and Masayuki Inoue. (1 Oct 2020). Discovery of Gramicidin A Analogues with Altered Activities by Multidimensional Screening of a One-Bead-One-Compound Library. Nature Communications. DOI: 10.1038/s41467-020-18711-2

Related Links
Earlier research project using the same technique on a different antibiotic: https://www.u-tokyo.ac.jp/focus/en/press/z0508_00059.html
Inoue Lab: http://www.f.u-tokyo.ac.jp/~inoue/e_index.html
Graduate School of Pharmaceutical Sciences: http://www.f.u-tokyo.ac.jp/en/

Research contact
Professor Masayuki Inoue
Email: inoue@mol.f.u-tokyo.ac.jp
Tel: +81-03-5841-1354

Press officer contacts
Ms. Caitlin Devor
Division for Strategic Public Relations, The University of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo 133-8654, JAPAN
Tel: +81-080-9707-8178
E-mail: press-releases.adm@gs.mail.u-tokyo.ac.jp

About the University of Tokyo
The University of Tokyo is Japan's leading university and one of the world's top research universities. The vast research output of some 6,000 researchers is published in the world's top journals across the arts and sciences. Our vibrant student body of around 15,000 undergraduate and 15,000 graduate students includes over 4,000 international students. Find out more at http://www.u-tokyo.ac.jp/en/ or follow us on Twitter at @UTokyo_News_en.

University of Tokyo

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.